150 related articles for article (PubMed ID: 18802010)
1. Primary lymphoma of the central nervous system: just DLBCL or not?
Montesinos-Rongen M; Siebert R; Deckert M
Blood; 2009 Jan; 113(1):7-10. PubMed ID: 18802010
[No Abstract] [Full Text] [Related]
2. High frequency of inactivating tetraspanin
Elfrink S; de Winde CM; van den Brand M; Berendsen M; Roemer MGM; Arnold F; Janssen L; van der Schaaf A; Jansen E; Groenen PJTA; Eijkelenboom A; Stevens W; Hess CJ; van Krieken JH; Vermaat JSP; Cleven AHG; de Groen RAL; Neviani V; de Jong D; van Deventer S; Scheijen B; van Spriel AB
Blood; 2019 Sep; 134(12):946-950. PubMed ID: 31366619
[TBL] [Abstract][Full Text] [Related]
3. Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.
Cambruzzi E
World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845
[TBL] [Abstract][Full Text] [Related]
4. Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.
Zuckerman NS; McCann KJ; Ottensmeier CH; Barak M; Shahaf G; Edelman H; Dunn-Walters D; Abraham RS; Stevenson FK; Mehr R
Int Immunol; 2010 Nov; 22(11):875-87. PubMed ID: 21059768
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles of central nervous system lymphoma predict poor survival in patients with diffuse large B-cell lymphoma.
Kagoya Y; Nannya Y; Nakamura F; Kurokawa M
Br J Haematol; 2014 Sep; 166(5):794-7. PubMed ID: 24749697
[No Abstract] [Full Text] [Related]
6. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract][Full Text] [Related]
7. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
8. PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.
Four M; Cacheux V; Tempier A; Platero D; Fabbro M; Marin G; Leventoux N; Rigau V; Costes-Martineau V; Szablewski V
Hematol Oncol; 2017 Dec; 35(4):487-496. PubMed ID: 27966264
[TBL] [Abstract][Full Text] [Related]
9. [Primary central nervous system lymphoma: pathogenesis and histomorphology].
Méhes G
Magy Onkol; 2017 Mar; 61(1):81-87. PubMed ID: 28273192
[TBL] [Abstract][Full Text] [Related]
10. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
12. Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.
Brunn A; Nagel I; Montesinos-Rongen M; Klapper W; Vater I; Paulus W; Hans V; Blümcke I; Weis J; Siebert R; Deckert M
Acta Neuropathol; 2013 Oct; 126(4):603-5. PubMed ID: 24061549
[No Abstract] [Full Text] [Related]
13. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
14. Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system.
Barranco GI; Fernández S; Oña R; González-Rincón J; Martínez-Ramírez A; Teijo A; Camacho FI; Pinedo FJ; Sánchez-Beato M; Pedrosa L; de la Fuente A; Estévez M; Iglesias R; Montalbán C; García JF
Haematologica; 2019 Jul; 104(7):e326-e329. PubMed ID: 30890596
[No Abstract] [Full Text] [Related]
15. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system lymphomas associated with chronic inflammation: diagnostic pitfalls of central nervous system lymphomas.
Sugita Y; Masuoka J; Kameda K; Takahashi K; Kimura Y; Higaki K; Furuta T; Ohshima K
Brain Tumor Pathol; 2020 Oct; 37(4):127-135. PubMed ID: 32627089
[TBL] [Abstract][Full Text] [Related]
17. Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma.
Ollila TA; Kurt H; Waroich J; Vatkevich J; Sturtevant A; Patel NR; Dubielecka PM; Treaba DO; Olszewski AJ
Blood; 2021 Feb; 137(8):1120-1124. PubMed ID: 32877514
[No Abstract] [Full Text] [Related]
18. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
[TBL] [Abstract][Full Text] [Related]
19. [Primary central nervous system diffuse large B cell lymphoma: a clinicopathologic and molecular study].
Ma ZP; Ainiwaer B; Liu ZY; Shi XL; Cui WL; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):762-768. PubMed ID: 27821230
[No Abstract] [Full Text] [Related]
20. Hyper-
Thurner L; Preuss KD; Bewarder M; Kemele M; Fadle N; Regitz E; Altmeyer S; Schormann C; Poeschel V; Ziepert M; Walter S; Roth P; Weller M; Szczepanowski M; Klapper W; Monoranu C; Rosenwald A; Möller P; Hartmann S; Hansmann ML; Mackensen A; Schäfer H; Schorb E; Illerhaus G; Buslei R; Bohle RM; Stilgenbauer S; Kim YJ; Pfreundschuh M
Blood; 2018 Dec; 132(26):2744-2753. PubMed ID: 30249786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
